عرض بسيط للتسجيلة

المؤلفDania, Kattan
المؤلفBarsa, Chloe
المؤلفMekhijian, Sarin
المؤلفShakkour, Zaynab
المؤلفJammoul, Maya
المؤلفDoumit, Mark
المؤلفZabala, Maria Camila Pareja
المؤلفDarwiche, Nadine
المؤلفEid, Ali H.
المؤلفMechref, Yehia
المؤلفWang, Kevin K.
المؤلفde Rivero Vaccari, Juan Pablo
المؤلفMunoz Pareja, Jennifer C.
المؤلفKobeissy, Firas
تاريخ الإتاحة2023-01-30T07:10:26Z
تاريخ النشر2023-01-31
اسم المنشورNeuroscience & Biobehavioral Reviews
المعرّفhttp://dx.doi.org/10.1016/j.neubiorev.2022.104969
الاقتباسKattan D, Barsa C, Mekhijian S, et al. Inflammasomes as biomarkers and therapeutic targets in traumatic brain injury and related-neurodegenerative diseases: A comprehensive overview. Neurosci Biobehav Rev. 2023;144:104969. doi:10.1016/j.neubiorev.2022.104969
الرقم المعياري الدولي للكتاب01497634
معرّف المصادر الموحدhttps://www.sciencedirect.com/science/article/pii/S0149763422004584
معرّف المصادر الموحدhttp://hdl.handle.net/10576/39172
الملخصGiven the ambiguity surrounding traumatic brain injury (TBI) pathophysiology and the lack of any Food and Drug Administration (FDA)-approved neurotherapeutic drugs, there is an increasing need to better understand the mechanisms of TBI. Recently, the roles of inflammasomes have been highlighted as both potential therapeutic targets and diagnostic markers in different neurodegenerative disorders. Indeed, inflammasome activation plays a pivotal function in the central nervous system (CNS) response to many neurological conditions, as well as to several neurodegenerative disorders, specifically, TBI. This comprehensive review summarizes and critically discusses the mechanisms that govern the activation and assembly of inflammasome complexes and the major methods used to study inflammasome activation in TBI and its implication for other neurodegenerative disorders. Also, we will review how inflammasome activation is critical in CNS homeostasis and pathogenesis, and how it can impact chronic TBI sequalae and increase the risk of developing neurodegenerative diseases. Additionally, we discuss the recent updates on inflammasome-related biomarkers and the potential to utilize inflammasomes as putative therapeutic targets that hold the potential to better diagnose and treat subjects with TBI.
راعي المشروعThis work is partially supported by the grant "UL1TR002736, Miami Clinical, and Translational Science Institute, from the National Center for Advancing Translational Sciences and the National Institute on Minority Health and Health Disparities" (PI: J C. Munoz Pareja). Additionally, this work was also supported by grants from NIH for (PI: Yehia Mechref) (1R01GM112490-09, 1U01CA225753-05, and 1R01GM130091-04) and for (PI: JPdRV) (1R01NS113969-01, 1RF1NS125578-01).
اللغةen
الناشرElsevier
الموضوعInflammasomes
Traumatic brain injury
Neurodegenerative diseases
Caspase-1
Pyroptosis
Biomarkers
Therapeutic targets
NLPR1
العنوانInflammasomes as biomarkers and therapeutic targets in traumatic brain injury and related-neurodegenerative diseases: A comprehensive overview
النوعArticle
رقم المجلد144
dc.accessType Open Access


الملفات في هذه التسجيلة

Thumbnail

هذه التسجيلة تظهر في المجموعات التالية

عرض بسيط للتسجيلة